BIOMERICA INC Interest and Dividend Income, Operating
BIOMERICA INC (BMRA) reported Interest and Dividend Income, Operating of $1.23 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InterestAndDividendIncomeOperating · last filed 2026-08-31
- BIOMERICA INC interest and dividend income, operating for the quarter ending 2025-11-30 was $58.00K, a 45.00% increase year-over-year.
- BIOMERICA INC interest and dividend income, operating for the quarter ending 2025-08-31 was $1.12M, a 1905.36% increase year-over-year.
- BIOMERICA INC interest and dividend income, operating for the quarter ending 2025-05-31 was $25.00K, a 78.07% decline year-over-year.
- BIOMERICA INC interest and dividend income, operating for the quarter ending 2025-02-28 was $43.00K, a 50.00% decline year-over-year.
- BIOMERICA INC interest and dividend income, operating for fiscal 2026 was $1.23M, a 647.27% increase from fiscal 2025.
- BIOMERICA INC interest and dividend income, operating for fiscal 2025 was $165.00K, a 61.72% decline from fiscal 2024.
- BIOMERICA INC interest and dividend income, operating for fiscal 2024 was $431.00K, a 224.06% increase from fiscal 2023.
- BIOMERICA INC interest and dividend income, operating for fiscal 2023 was $133.00K.
| Period end | Interest and Dividend Income, Operating 3 month | Interest and Dividend Income, Operating 6 month | Interest and Dividend Income, Operating 9 month | Interest and Dividend Income, Operating 12 month |
|---|---|---|---|---|
| 2026-05-31 | $1.23M 10-K · filed 2026-08-31 | |||
| 2025-11-30 | $58.00K 10-Q · filed 2026-01-14 | $1.18M 10-Q · filed 2026-01-14 | $1.21M derived: sum of 3 quarters · filed 2026-08-31 | $1.25M derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-08-31 | $1.12M 10-Q · filed 2025-10-14 | $1.15M derived: sum of 2 quarters · filed 2026-08-31 | $1.19M derived: sum of 3 quarters · filed 2026-08-31 | $1.23M derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-05-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $68.00K derived: sum of 2 quarters · filed 2026-08-31 | $108.00K derived: sum of 3 quarters · filed 2026-08-31 | $165.00K 10-K · filed 2026-08-31 |
| 2025-02-28 | $43.00K 10-Q · filed 2025-04-14 | $83.00K derived: sum of 2 quarters · filed 2026-01-14 | $140.00K 10-Q · filed 2025-04-14 | $253.00K derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-11-30 | $40.00K 10-Q · filed 2026-01-14 | $97.00K 10-Q · filed 2026-01-14 | $210.00K derived: sum of 3 quarters · filed 2026-01-14 | $296.00K derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-08-31 | $56.00K 10-Q · filed 2025-10-14 | $170.00K derived: sum of 2 quarters · filed 2025-10-14 | $256.00K derived: sum of 3 quarters · filed 2025-10-14 | $365.00K derived: sum of 4 quarters · filed 2025-10-14 |
| 2024-05-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $200.00K derived: sum of 2 quarters · filed 2025-08-29 | $309.00K derived: sum of 3 quarters · filed 2025-08-29 | $431.00K 10-K · filed 2025-08-29 |
| 2024-02-29 | $86.00K 10-Q · filed 2025-04-14 | $195.00K derived: sum of 2 quarters · filed 2025-04-14 | $317.00K 10-Q · filed 2025-04-14 | $374.00K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | $109.00K 10-Q · filed 2025-01-14 | $231.00K 10-Q · filed 2025-01-14 | $288.00K derived: sum of 3 quarters · filed 2025-01-14 | $324.00K derived: sum of 4 quarters · filed 2025-01-14 |
| 2023-08-31 | $123.00K 10-Q · filed 2024-10-15 | $179.00K derived: sum of 2 quarters · filed 2024-10-15 | $215.00K derived: sum of 3 quarters · filed 2024-10-15 | $256.00K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $92.00K derived: sum of 2 quarters · filed 2024-08-28 | $133.00K derived: sum of 3 quarters · filed 2024-08-28 | $133.00K 10-K · filed 2024-08-28 |
| 2023-02-28 | $36.00K 10-Q · filed 2024-04-12 | $77.00K derived: sum of 2 quarters · filed 2024-04-12 | $77.00K 10-Q · filed 2024-04-12 | |
| 2022-11-30 | $41.00K 10-Q · filed 2024-01-16 | $41.00K 10-Q · filed 2024-01-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |